Open1.090 | Close1.040 |
Vol / Avg.48.198K / 140.386K | Mkt Cap31.917M |
Day Range1.000 - 1.090 | 52 Wk Range0.901 - 3.950 |
IN8bio Stock (NASDAQ: INAB) stock price, news, charts, stock research, profile.
Open1.090 | Close1.040 |
Vol / Avg.48.198K / 140.386K | Mkt Cap31.917M |
Day Range1.000 - 1.090 | 52 Wk Range0.901 - 3.950 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.270 | -0.270 | 0.0000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-11 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
2023-06-05 | EF Hutton | Tony Butler | Reiterates | BuyBuy | Maintains | - | 8.00 |
2023-05-16 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
2023-04-26 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | Buy | Maintains | - | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
INAB | IN8bio | -9.01% | 31.9M |
FBIO | Fortress Biotech | 6.67% | 42.6M |
COEP | Coeptis Therapeutics | 10.28% | 34.4M |
ALGS | Aligos Therapeutics | 2.33% | 32.5M |
BOLT | Bolt Biotherapeutics | -3.85% | 38M |
You can purchase shares of IN8bio (NASDAQ: INAB) through any online brokerage.
Other companies in IN8bio’s space includes: Fortress Biotech (NASDAQ:FBIO), Coeptis Therapeutics (NASDAQ:COEP), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT) and NuCana (NASDAQ:NCNA).
The latest price target for IN8bio (NASDAQ: INAB) was reported by HC Wainwright & Co. on Friday, August 11, 2023. The analyst firm set a price target for 14.00 expecting INAB to rise to within 12 months (a possible 1286.14% upside). 10 analyst firms have reported ratings in the last year.
The stock price for IN8bio (NASDAQ: INAB) is $1.01 last updated September 29, 2023 at 11:33 PM UTC.
There is no dividend information for IN8bio.
IN8bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for IN8bio.
IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
IN8bio Stock (NASDAQ: INAB) stock price, news, charts, stock research, profile.
Open1.090 | Close1.040 |
Vol / Avg.48.198K / 140.386K | Mkt Cap31.917M |
Day Range1.000 - 1.090 | 52 Wk Range0.901 - 3.950 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.270 | -0.270 | 0.0000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-11 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
2023-06-05 | EF Hutton | Tony Butler | Reiterates | BuyBuy | Maintains | - | 8.00 |
2023-05-16 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
2023-04-26 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | Buy | Maintains | - | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
INAB | IN8bio | -9.01% | 31.9M |
FBIO | Fortress Biotech | 6.67% | 42.6M |
COEP | Coeptis Therapeutics | 10.28% | 34.4M |
ALGS | Aligos Therapeutics | 2.33% | 32.5M |
BOLT | Bolt Biotherapeutics | -3.85% | 38M |
You can purchase shares of IN8bio (NASDAQ: INAB) through any online brokerage.
Other companies in IN8bio’s space includes: Fortress Biotech (NASDAQ:FBIO), Coeptis Therapeutics (NASDAQ:COEP), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT) and NuCana (NASDAQ:NCNA).
The latest price target for IN8bio (NASDAQ: INAB) was reported by HC Wainwright & Co. on Friday, August 11, 2023. The analyst firm set a price target for 14.00 expecting INAB to rise to within 12 months (a possible 1286.14% upside). 10 analyst firms have reported ratings in the last year.
The stock price for IN8bio (NASDAQ: INAB) is $1.01 last updated September 29, 2023 at 11:33 PM UTC.
There is no dividend information for IN8bio.
IN8bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for IN8bio.
IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
IN8bio Stock (NASDAQ: INAB) stock price, news, charts, stock research, profile.
Open1.090 | Close1.040 |
Vol / Avg.48.198K / 140.386K | Mkt Cap31.917M |
Day Range1.000 - 1.090 | 52 Wk Range0.901 - 3.950 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.270 | -0.270 | 0.0000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-11 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
2023-06-05 | EF Hutton | Tony Butler | Reiterates | BuyBuy | Maintains | - | 8.00 |
2023-05-16 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
2023-04-26 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | Buy | Maintains | - | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
INAB | IN8bio | -9.01% | 31.9M |
FBIO | Fortress Biotech | 6.67% | 42.6M |
COEP | Coeptis Therapeutics | 10.28% | 34.4M |
ALGS | Aligos Therapeutics | 2.33% | 32.5M |
BOLT | Bolt Biotherapeutics | -3.85% | 38M |
You can purchase shares of IN8bio (NASDAQ: INAB) through any online brokerage.
Other companies in IN8bio’s space includes: Fortress Biotech (NASDAQ:FBIO), Coeptis Therapeutics (NASDAQ:COEP), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT) and NuCana (NASDAQ:NCNA).
The latest price target for IN8bio (NASDAQ: INAB) was reported by HC Wainwright & Co. on Friday, August 11, 2023. The analyst firm set a price target for 14.00 expecting INAB to rise to within 12 months (a possible 1286.14% upside). 10 analyst firms have reported ratings in the last year.
The stock price for IN8bio (NASDAQ: INAB) is $1.01 last updated September 29, 2023 at 11:33 PM UTC.
There is no dividend information for IN8bio.
IN8bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for IN8bio.
IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
IN8bio Stock (NASDAQ: INAB) stock price, news, charts, stock research, profile.
Open1.090 | Close1.040 |
Vol / Avg.48.198K / 140.386K | Mkt Cap31.917M |
Day Range1.000 - 1.090 | 52 Wk Range0.901 - 3.950 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.270 | -0.270 | 0.0000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-11 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
2023-06-05 | EF Hutton | Tony Butler | Reiterates | BuyBuy | Maintains | - | 8.00 |
2023-05-16 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
2023-04-26 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | Buy | Maintains | - | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
INAB | IN8bio | -9.01% | 31.9M |
FBIO | Fortress Biotech | 6.67% | 42.6M |
COEP | Coeptis Therapeutics | 10.28% | 34.4M |
ALGS | Aligos Therapeutics | 2.33% | 32.5M |
BOLT | Bolt Biotherapeutics | -3.85% | 38M |
You can purchase shares of IN8bio (NASDAQ: INAB) through any online brokerage.
Other companies in IN8bio’s space includes: Fortress Biotech (NASDAQ:FBIO), Coeptis Therapeutics (NASDAQ:COEP), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT) and NuCana (NASDAQ:NCNA).
The latest price target for IN8bio (NASDAQ: INAB) was reported by HC Wainwright & Co. on Friday, August 11, 2023. The analyst firm set a price target for 14.00 expecting INAB to rise to within 12 months (a possible 1286.14% upside). 10 analyst firms have reported ratings in the last year.
The stock price for IN8bio (NASDAQ: INAB) is $1.01 last updated September 29, 2023 at 11:33 PM UTC.
There is no dividend information for IN8bio.
IN8bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for IN8bio.
IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
IN8bio Stock (NASDAQ: INAB) stock price, news, charts, stock research, profile.
Open1.090 | Close1.040 |
Vol / Avg.48.198K / 140.386K | Mkt Cap31.917M |
Day Range1.000 - 1.090 | 52 Wk Range0.901 - 3.950 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.270 | -0.270 | 0.0000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-11 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
2023-06-05 | EF Hutton | Tony Butler | Reiterates | BuyBuy | Maintains | - | 8.00 |
2023-05-16 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
2023-04-26 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | Buy | Maintains | - | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
INAB | IN8bio | -9.01% | 31.9M |
FBIO | Fortress Biotech | 6.67% | 42.6M |
COEP | Coeptis Therapeutics | 10.28% | 34.4M |
ALGS | Aligos Therapeutics | 2.33% | 32.5M |
BOLT | Bolt Biotherapeutics | -3.85% | 38M |
You can purchase shares of IN8bio (NASDAQ: INAB) through any online brokerage.
Other companies in IN8bio’s space includes: Fortress Biotech (NASDAQ:FBIO), Coeptis Therapeutics (NASDAQ:COEP), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT) and NuCana (NASDAQ:NCNA).
The latest price target for IN8bio (NASDAQ: INAB) was reported by HC Wainwright & Co. on Friday, August 11, 2023. The analyst firm set a price target for 14.00 expecting INAB to rise to within 12 months (a possible 1286.14% upside). 10 analyst firms have reported ratings in the last year.
The stock price for IN8bio (NASDAQ: INAB) is $1.01 last updated September 29, 2023 at 11:33 PM UTC.
There is no dividend information for IN8bio.
IN8bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for IN8bio.
IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
IN8bio Stock (NASDAQ: INAB) stock price, news, charts, stock research, profile.
Open1.090 | Close1.040 |
Vol / Avg.48.198K / 140.386K | Mkt Cap31.917M |
Day Range1.000 - 1.090 | 52 Wk Range0.901 - 3.950 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.270 | -0.270 | 0.0000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-11 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
2023-06-05 | EF Hutton | Tony Butler | Reiterates | BuyBuy | Maintains | - | 8.00 |
2023-05-16 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
2023-04-26 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | Buy | Maintains | - | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
INAB | IN8bio | -9.01% | 31.9M |
FBIO | Fortress Biotech | 6.67% | 42.6M |
COEP | Coeptis Therapeutics | 10.28% | 34.4M |
ALGS | Aligos Therapeutics | 2.33% | 32.5M |
BOLT | Bolt Biotherapeutics | -3.85% | 38M |
You can purchase shares of IN8bio (NASDAQ: INAB) through any online brokerage.
Other companies in IN8bio’s space includes: Fortress Biotech (NASDAQ:FBIO), Coeptis Therapeutics (NASDAQ:COEP), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT) and NuCana (NASDAQ:NCNA).
The latest price target for IN8bio (NASDAQ: INAB) was reported by HC Wainwright & Co. on Friday, August 11, 2023. The analyst firm set a price target for 14.00 expecting INAB to rise to within 12 months (a possible 1286.14% upside). 10 analyst firms have reported ratings in the last year.
The stock price for IN8bio (NASDAQ: INAB) is $1.01 last updated September 29, 2023 at 11:33 PM UTC.
There is no dividend information for IN8bio.
IN8bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for IN8bio.
IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
IN8bio Stock (NASDAQ: INAB) stock price, news, charts, stock research, profile.
Open1.090 | Close1.040 |
Vol / Avg.48.198K / 140.386K | Mkt Cap31.917M |
Day Range1.000 - 1.090 | 52 Wk Range0.901 - 3.950 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.270 | -0.270 | 0.0000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-11 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
2023-06-05 | EF Hutton | Tony Butler | Reiterates | BuyBuy | Maintains | - | 8.00 |
2023-05-16 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
2023-04-26 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | Buy | Maintains | - | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
INAB | IN8bio | -9.01% | 31.9M |
FBIO | Fortress Biotech | 6.67% | 42.6M |
COEP | Coeptis Therapeutics | 10.28% | 34.4M |
ALGS | Aligos Therapeutics | 2.33% | 32.5M |
BOLT | Bolt Biotherapeutics | -3.85% | 38M |
You can purchase shares of IN8bio (NASDAQ: INAB) through any online brokerage.
Other companies in IN8bio’s space includes: Fortress Biotech (NASDAQ:FBIO), Coeptis Therapeutics (NASDAQ:COEP), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT) and NuCana (NASDAQ:NCNA).
The latest price target for IN8bio (NASDAQ: INAB) was reported by HC Wainwright & Co. on Friday, August 11, 2023. The analyst firm set a price target for 14.00 expecting INAB to rise to within 12 months (a possible 1286.14% upside). 10 analyst firms have reported ratings in the last year.
The stock price for IN8bio (NASDAQ: INAB) is $1.01 last updated September 29, 2023 at 11:33 PM UTC.
There is no dividend information for IN8bio.
IN8bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for IN8bio.
IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
IN8bio Stock (NASDAQ: INAB) stock price, news, charts, stock research, profile.
Open1.090 | Close1.040 |
Vol / Avg.48.198K / 140.386K | Mkt Cap31.917M |
Day Range1.000 - 1.090 | 52 Wk Range0.901 - 3.950 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.270 | -0.270 | 0.0000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-11 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
2023-06-05 | EF Hutton | Tony Butler | Reiterates | BuyBuy | Maintains | - | 8.00 |
2023-05-16 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
2023-04-26 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | Buy | Maintains | - | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
INAB | IN8bio | -9.01% | 31.9M |
FBIO | Fortress Biotech | 6.67% | 42.6M |
COEP | Coeptis Therapeutics | 10.28% | 34.4M |
ALGS | Aligos Therapeutics | 2.33% | 32.5M |
BOLT | Bolt Biotherapeutics | -3.85% | 38M |
You can purchase shares of IN8bio (NASDAQ: INAB) through any online brokerage.
Other companies in IN8bio’s space includes: Fortress Biotech (NASDAQ:FBIO), Coeptis Therapeutics (NASDAQ:COEP), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT) and NuCana (NASDAQ:NCNA).
The latest price target for IN8bio (NASDAQ: INAB) was reported by HC Wainwright & Co. on Friday, August 11, 2023. The analyst firm set a price target for 14.00 expecting INAB to rise to within 12 months (a possible 1286.14% upside). 10 analyst firms have reported ratings in the last year.
The stock price for IN8bio (NASDAQ: INAB) is $1.01 last updated September 29, 2023 at 11:33 PM UTC.
There is no dividend information for IN8bio.
IN8bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for IN8bio.
IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
IN8bio Stock (NASDAQ: INAB) stock price, news, charts, stock research, profile.
Open1.090 | Close1.040 |
Vol / Avg.48.198K / 140.386K | Mkt Cap31.917M |
Day Range1.000 - 1.090 | 52 Wk Range0.901 - 3.950 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.270 | -0.270 | 0.0000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-11 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
2023-06-05 | EF Hutton | Tony Butler | Reiterates | BuyBuy | Maintains | - | 8.00 |
2023-05-16 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | BuyBuy | Maintains | - | 14.00 |
2023-04-26 | HC Wainwright & Co. | Swayampakula Ramakanth | Reiterates | Buy | Maintains | - | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
INAB | IN8bio | -9.01% | 31.9M |
FBIO | Fortress Biotech | 6.67% | 42.6M |
COEP | Coeptis Therapeutics | 10.28% | 34.4M |
ALGS | Aligos Therapeutics | 2.33% | 32.5M |
BOLT | Bolt Biotherapeutics | -3.85% | 38M |
You can purchase shares of IN8bio (NASDAQ: INAB) through any online brokerage.
Other companies in IN8bio’s space includes: Fortress Biotech (NASDAQ:FBIO), Coeptis Therapeutics (NASDAQ:COEP), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT) and NuCana (NASDAQ:NCNA).
The latest price target for IN8bio (NASDAQ: INAB) was reported by HC Wainwright & Co. on Friday, August 11, 2023. The analyst firm set a price target for 14.00 expecting INAB to rise to within 12 months (a possible 1286.14% upside). 10 analyst firms have reported ratings in the last year.
The stock price for IN8bio (NASDAQ: INAB) is $1.01 last updated September 29, 2023 at 11:33 PM UTC.
There is no dividend information for IN8bio.
IN8bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for IN8bio.
IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.